Range Low Price High Price Comment
30 days $1.03 $1.03 Monday, 30th Oct 2023 SPPI stock ended at $1.03. During the day the stock fluctuated 0% from a day low at $1.03 to a day high of $1.03.
90 days $1.03 $1.03
52 weeks $0.315 $1.36

Historical Spectrum Pharmaceuticals prices

Date Open High Low Close Volume
Feb 01, 2016 $4.91 $4.99 $4.65 $4.84 1 003 200
Jan 29, 2016 $4.81 $4.96 $4.72 $4.96 892 200
Jan 28, 2016 $5.01 $5.08 $4.74 $4.77 1 044 600
Jan 27, 2016 $5.22 $5.28 $4.97 $4.98 700 200
Jan 26, 2016 $5.18 $5.24 $4.91 $5.23 545 100
Jan 25, 2016 $5.13 $5.32 $5.10 $5.13 717 100
Jan 22, 2016 $5.20 $5.28 $5.07 $5.19 906 500
Jan 21, 2016 $4.97 $5.28 $4.89 $5.13 882 000
Jan 20, 2016 $4.63 $5.04 $4.51 $4.99 1 365 700
Jan 19, 2016 $5.06 $5.08 $4.62 $4.71 1 064 400
Jan 15, 2016 $4.90 $5.00 $4.76 $4.98 973 200
Jan 14, 2016 $4.92 $5.20 $4.73 $5.04 1 444 600
Jan 13, 2016 $5.19 $5.31 $4.80 $4.86 1 096 100
Jan 12, 2016 $5.05 $5.29 $4.96 $5.19 1 263 300
Jan 11, 2016 $5.27 $5.27 $4.86 $5.01 1 055 100
Jan 08, 2016 $5.29 $5.34 $5.13 $5.21 629 600
Jan 07, 2016 $5.43 $5.43 $5.23 $5.24 577 400
Jan 06, 2016 $5.67 $5.68 $5.47 $5.52 561 400
Jan 05, 2016 $5.80 $5.84 $5.68 $5.73 446 200
Click to get the best stock tips daily for free!

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interfero... SPPI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT